tiprankstipranks
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
US Market

Inhibitor Therapeutics (INTI) Similar Stocks

26 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibitor Therapeutics
$13.50M
-5.74
66.67%
premium
Alnylam Pharma
$18.60B
-41.68
-27.88%
13 Buy
8 Hold
0 Sell
Moderate Buy
premium
Crispr Therapeutics AG
$4.98B
-30.78
11.75%
10 Buy
5 Hold
2 Sell
Moderate Buy
premium
Gilead Sciences
$84.48B
15.04
-15.80%
10 Buy
11 Hold
0 Sell
Moderate Buy
premium
Moderna
$39.77B
-8.48
-26.97%
8 Buy
6 Hold
2 Sell
Moderate Buy
premium

Performance Comparison

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis